大幸薬品の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2014/06/23 | 1,541 | 1,558 | 1,534 | 1,543 | +2 | +0.1% | 92,500 |
2014/06/20 | 1,553 | 1,555 | 1,535 | 1,541 | -9 | -0.6% | 104,800 |
2014/06/19 | 1,558 | 1,560 | 1,546 | 1,550 | +5 | +0.3% | 142,300 |
2014/06/18 | 1,525 | 1,546 | 1,515 | 1,545 | +20 | +1.3% | 167,400 |
2014/06/17 | 1,500 | 1,525 | 1,486 | 1,525 | +36 | +2.4% | 138,700 |
2014/06/16 | 1,517 | 1,527 | 1,481 | 1,489 | -18 | -1.2% | 194,300 |
2014/06/13 | 1,465 | 1,510 | 1,464 | 1,507 | +35 | +2.4% | 189,600 |
2014/06/12 | 1,455 | 1,478 | 1,442 | 1,472 | +16 | +1.1% | 192,200 |
2014/06/11 | 1,461 | 1,472 | 1,453 | 1,456 | -9 | -0.6% | 198,900 |
2014/06/10 | 1,470 | 1,484 | 1,460 | 1,465 | -8 | -0.5% | 229,600 |
2014/06/09 | 1,480 | 1,484 | 1,471 | 1,473 | -7 | -0.5% | 204,400 |
2014/06/06 | 1,482 | 1,493 | 1,466 | 1,480 | -2 | -0.1% | 187,100 |
2014/06/05 | 1,527 | 1,529 | 1,462 | 1,482 | -45 | -2.9% | 353,700 |
2014/06/04 | 1,550 | 1,556 | 1,526 | 1,527 | -53 | -3.4% | 291,000 |
2014/06/03 | 1,587 | 1,593 | 1,571 | 1,580 | +3 | +0.2% | 114,500 |
2014/06/02 | 1,565 | 1,579 | 1,550 | 1,577 | +29 | +1.9% | 133,600 |
2014/05/30 | 1,559 | 1,569 | 1,540 | 1,548 | -5 | -0.3% | 120,700 |
2014/05/29 | 1,537 | 1,555 | 1,537 | 1,553 | +18 | +1.2% | 134,600 |
2014/05/28 | 1,535 | 1,549 | 1,530 | 1,535 | +8 | +0.5% | 92,100 |
2014/05/27 | 1,552 | 1,555 | 1,521 | 1,527 | -24 | -1.5% | 151,300 |
2014/05/26 | 1,537 | 1,552 | 1,534 | 1,551 | +32 | +2.1% | 213,700 |
2014/05/23 | 1,468 | 1,529 | 1,448 | 1,519 | +86 | +6% | 386,100 |
2014/05/22 | 1,459 | 1,465 | 1,406 | 1,433 | -1 | -0.1% | 239,800 |
2014/05/21 | 1,401 | 1,448 | 1,400 | 1,434 | +70 | +5.1% | 496,800 |
2014/05/20 | 1,353 | 1,375 | 1,352 | 1,364 | +12 | +0.9% | 85,800 |
2014/05/19 | 1,359 | 1,379 | 1,350 | 1,352 | -11 | -0.8% | 101,800 |
2014/05/16 | 1,395 | 1,395 | 1,343 | 1,363 | -32 | -2.3% | 140,400 |
2014/05/15 | 1,359 | 1,400 | 1,355 | 1,395 | +25 | +1.8% | 183,100 |
2014/05/14 | 1,381 | 1,397 | 1,332 | 1,370 | -98 | -6.7% | 553,900 |
2014/05/13 | 1,460 | 1,472 | 1,452 | 1,468 | +11 | +0.8% | 128,900 |
2014/05/12 | 1,502 | 1,510 | 1,440 | 1,457 | -47 | -3.1% | 191,700 |
2014/05/09 | 1,511 | 1,518 | 1,495 | 1,504 | -6 | -0.4% | 107,000 |
2014/05/08 | 1,513 | 1,525 | 1,506 | 1,510 | -9 | -0.6% | 82,000 |
2014/05/07 | 1,509 | 1,526 | 1,509 | 1,519 | -19 | -1.2% | 110,800 |
2014/05/02 | 1,536 | 1,547 | 1,513 | 1,538 | +15 | +1% | 134,000 |
2014/05/01 | 1,480 | 1,525 | 1,479 | 1,523 | +37 | +2.5% | 157,700 |
2014/04/30 | 1,503 | 1,513 | 1,481 | 1,486 | -18 | -1.2% | 129,300 |
2014/04/28 | 1,520 | 1,523 | 1,493 | 1,504 | -23 | -1.5% | 174,500 |
2014/04/25 | 1,500 | 1,533 | 1,500 | 1,527 | +27 | +1.8% | 150,300 |
2014/04/24 | 1,525 | 1,525 | 1,496 | 1,500 | -16 | -1.1% | 123,800 |
2014/04/23 | 1,494 | 1,521 | 1,484 | 1,516 | +25 | +1.7% | 130,700 |
2014/04/22 | 1,535 | 1,538 | 1,481 | 1,491 | -37 | -2.4% | 197,800 |
2014/04/21 | 1,523 | 1,549 | 1,519 | 1,528 | +13 | +0.9% | 184,700 |
2014/04/18 | 1,521 | 1,527 | 1,501 | 1,515 | -4 | -0.3% | 134,200 |
2014/04/17 | 1,533 | 1,542 | 1,509 | 1,519 | -1 | -0.1% | 146,900 |
2014/04/16 | 1,504 | 1,528 | 1,498 | 1,520 | +27 | +1.8% | 221,300 |
2014/04/15 | 1,530 | 1,535 | 1,484 | 1,493 | -54 | -3.5% | 415,300 |
2014/04/14 | 1,620 | 1,643 | 1,531 | 1,547 | +50 | +3.3% | 1,286,200 |
2014/04/11 | 1,480 | 1,518 | 1,466 | 1,497 | -27 | -1.8% | 235,600 |
2014/04/10 | 1,540 | 1,580 | 1,515 | 1,524 | +19 | +1.3% | 304,500 |
2651~
2700
件表示中 / 3941件
類似銘柄と比較する
現在ご覧いただいている「大幸薬品」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
大幸薬品 | 27,600円 | +0.1% | -70.9% | 0.00% | 46.15倍 | 1.74倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。感染管理「クレベリン」事業は再構築中 |
CANBAS | 101,200円 | - | - | 0.00% | - | 6.48倍 |
|
抗がん剤開発に特化した創薬ベンチャー。主力の膵臓がん治療薬候補は自社開発。導出も模索 |
Chordia | 23,900円 | - | - | 0.00% | - | 5.08倍 |
|
RNA制御ストレスを標的とする低分子抗がん薬を開発中。開発品・研究者は武田にルーツ |
オンコリス | 55,800円 | +3771.0% | - | 0.00% | - | 5.06倍 |
|
腫瘍溶解ウイルス技術使うがん治療薬柱に感染症薬も開発。導出先が神経疾患薬を米国治験中 |
セルソース | 65,600円 | - | - | 0.76% | 50.97倍 | 2.17倍 |
|
脂肪・血液由来の細胞加工受託など再生医療、変形性ひざ関節症向け軸に不妊治療関連も展開 |
市場注目の銘柄
チャート関連のコラム